≡ Menu

KV Pharmaceutical Class Action Lawsuit Filed Over Makena Preterm Birth Drug

KV Pharmaceutical Co. Investor Files Shareholder Class Action Lawsuit Complaint Against KV Pharmaceutical Over Makena Preterm Birth Drug Pricing.

A class action lawsuit has reportedly been filed against KV Pharmaceutical Co. (“KV Pharmaceutical” or “Defendant”) in the United States District Court for the Eastern District of Missouri in St. Louis (styled Julianello v. KV Pharmaceutical Co., Class Action Case No. 11-cv-1816) alleging, among other things, that  KV Pharmaceutical misled shareholders about the pricing of its preterm birth drug Makena, according to a KV Pharmaceutical Makena Preterm or Premature Birth Drug class action lawsuit news report.

If You Have Thoughts On The KV Pharmaceutical Makena Preterm & Premature Birth Drug Class Action Lawsuit, Share Your Class Action Comments Below.

{ 0 comments… add one }

What Do You Think? Share Your Class Action Lawsuit & Settlement Comments With Others Below.